Immunic is trading at $6.53 (-5.30%) as hotter-than-forecast September inflation lifted Treasury yields and heightened rate-hike concerns.
- Higher yields have pressured equities amid broader weakness: the S&P 500 fell 1.11% and the Nasdaq fell 1.68%.
- No clear new company-specific catalyst was identified; Immunic’s latest reported release was routine inducement grants dated October 13.